Encellin

Empowering living medicines for endocrine disorders

San Francisco, United States · $15.8M raised

Employees
11–50
Business Model
B2B
Total Funding
$15.8M
Last Round
$9.9M Series ADec 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Encellin is a biotechnology company pioneering living medicine platforms to address high unmet clinical needs, starting with endocrine disorders. The company has developed an Encapsulated Cell Replacement Therapy (ENCRT) that enables enclosed cells to function like smart molecular factories, releasing therapeutics when needed — with a lead program targeting hypoglycemia in type 1 diabetes. Encellin's minimally invasive implant platform is designed to deliver years of sophisticated cell-based therapies from a single implant, and the company has demonstrated first-in-human non-fibrotic engraftment of viable encapsulated human islets.

Summary

Encellin is a Biotech company based in San Francisco, United States. It has raised $15.8M in total across 2 rounds, most recently a $9.9M Series A round in Dec 2023. Investors include Khosla Ventures, Sv Latam Capital and Y Combinator.

Funding History

Series ASeries ADec 2023
$9.9M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Encellin on Indexed.vc
<a href="https://indexed.vc/companies/encellin"><img src="https://indexed.vc/api/badge/company/encellin" alt="Encellin on Indexed.vc" width="260" height="76" /></a>